|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ProGRP: a new biomarker for small cell lung cancer显示文摘 | Molina R Filella X Auge J M | 2004 | Clinical Biochem2004，37，： | 1 |
| 2 | Prospective evalua- tion of procalcitonin in aduhs with febrile neutropenia after haematopoietic stem cell transplantation显示文摘 | Ortega M Rovira M Filella X | 2004 | Br J Haematol2004，126，3： | 1 |
| 3 | Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms显示文摘 | Filella X Truan D Alcover J | 2004 | Urology2004，63，6： | 1 |
| 4 | Tumor markers (CEA, CA125, CyFRA21-1, SCC and NSE) in patients with non-small cell lung cancer as aid in histoligical diangnosis and prognosis:comparison with the main clinical and pathological prognostic factors 显示文摘 | Molina R Filella X Auge JM | 2003 | Tumor Biol2003，24，4： | 1 |
| 5 | Impact of uhrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction 显示文摘 | Casals G Filella X Aug6 JM | 2008 | Am J Clin Pathol2008，130，6： | 1 |
| 6 | Comparison of Ser- um Huamn Epidymis Protein 4 with Cancer Antigen 125 as a Tumor Maker in Patients with Maligant and Nonmaligant Dis- ease显示文摘 | Escudero JM Auge JM Filella X | 2011 | Clin Chem2011，57，11： | 1 |
| 7 | Cancer antigen 125 in serum and ascitie fluid of patients with liver diseases显示文摘 | Molina R Filella X Bruix J | 1991 | Clin Chem1991，37，8： | 1 |
| 8 | Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases显示文摘 | Molina R Filella X Bruix J | 1991 | Clin Chem1991，37，8： | 1 |
| 9 | Complexed prostate-specific antigen for the detection of prostate cancer显示文摘 | Filella X Tman D Aleover J | | Antieancer Res0，24，： | 1 |
| 10 | Relationship of p53 with other on- cogenes, cytokines and systemic lupus erythematosus activity 显示文摘 | Miter C Molina R Filella X | 2003 | Turnout Bio2003，24，： | 1 |
| 11 | Tumor markers in response monitoring and prognosis of non small cell lung cancer:preliminary report显示文摘 | Vinolas N Molina R Galan M C Casas F Callejas M A Filella X | 1998 | Anticancer Res1998，18，1： | 1 |
| 12 | Cancer antigen CA125 in serum and ascitic fluid of patients with liver disease显示文摘 | Molina R Filella X Bruix J | 1991 | Clin Chem1991，37，8： | 1 |
| 13 | Carcinoembryonic Antigen in Staging and Follow-up of Patients with Solid Tumors显示文摘 | Ballesta A M Molina R Filella X Gimenez N | 1995 | Tumor Biol1995，，16： | 1 |
| 14 | Analysis of type T1 and T2 cytokines in patients with prostate cancer显示文摘 | Filella X Alcover J Zarco MA et at | 2000 | Prostate2000，44，4： | 1 |
| 15 | Pro-gastrin-releasing peptide (proGRP)in patients with benign and malignant diseases:comparison with CEA,SCC,CYFRA21-1 and NSE in patients with lung cancer显示文摘 | Molina R Auge JM Filella X | 2005 | Anticancer Research2005，25，3： | 1 |
| 16 | Detection of nonprostatic PSA in serum and nonserum samples from women 显示文摘 | Filella X Molina R Alcover J | 1996 | International Journal of Cancer1996，68，4： | 1 |
| 17 | Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: compari- son with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer 显示文摘 | Molina R Auge JM Filella X | 2005 | Antieancer Res2005，25，3： | 1 |
| 18 | Semmcytokines ( IL-6, TNF-α, IL-1 beta and IFN-gamma)in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity显示文摘 | Gratacos J Collado A Filella X | 1994 | Br J Rheumatol1994，33，10： | 1 |
| 19 | CA 125 in biological fluids显示文摘 | Molina R Filella X Jo J | 1998 | Int J Biol Markers1998，13，： | 1 |
| 20 | Serum levels of C-erbB-2(HER-2/neu)in patients with malignant and non-malignant diseases显示文摘 | JO J FILELLA X | 1997 | Tumour Biol1997，18，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员